OTR Therapeutics
- Headquarters
- Shanghai
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- otr-tx.com
- Total Funding
- $100.0M
- Last Round
- $100.0M Series AJun 2025
About
OTR Therapeutics is a Shanghai-based biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies for critical diseases with high unmet medical needs. The company focuses on oncology, immunology and inflammation, and cardiometabolic diseases, combining internal discovery with strategic acquisition of preclinical and early-stage assets. Founded in March 2025, it raised a $100M Series A backed by Temasek's True Light Capital, LAV, Pfizer Ventures, and Sirona Capital.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account